January 4, 2018 / 1:24 PM / Updated 11 minutes ago BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300 Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Protagonist Therapeutics Inc: 
* PROTAGONIST THERAPEUTICS GRANTED TWO NEW US PATENTS FOR PEPTIDE DRUG CANDIDATES PTG-100 AND PTG-300 Source text for Eikon: Further company coverage: